Axovant Fiscal Q3 Earnings Snapshot

SIOXDelisted Stock  USD 0.40  0.01  2.56%   
Slightly above 55% of Sio Gene's investors are presently thinking to get in. The analysis of current outlook of investing in Sio Gene Therapies suggests that some traders are interested regarding Sio Gene's prospects. Sio Gene's investing sentiment can be driven by a variety of factors including economic data, Sio Gene's earnings reports, geopolitical events, and overall market trends.
  
NEW YORK Axovant Sciences Ltd. on Tuesday reported a loss of 4 million in its fiscal third quarter. On a per-share basis, the New York-based company said it had a loss of 5 cents. This story was generated by Automated Insights using data from Zacks Investment Research.

Read at finance.yahoo.com
Yahoo News
  

Sio Gene Fundamental Analysis

We analyze Sio Gene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sio Gene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sio Gene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Debt To Equity

Debt To Equity Comparative Analysis

Sio Gene is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Sio Gene Therapies Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sio Gene stock to make a market-neutral strategy. Peer analysis of Sio Gene could also be used in its relative valuation, which is a method of valuing Sio Gene by comparing valuation metrics with similar companies.

Peers

Sio Gene Related Equities

SRZNSurrozen   19.37   
0%
100.0%
ALGSAligos Therapeutics   10.96   
0%
56.0%
MNPRMonopar Therapeutics   8.84   
0%
45.0%
VINCVincerx Pharma   7.69   
0%
39.0%
CTMXCytomX Therapeutics   3.92   
0%
20.0%
VCNXVaccinex   2.44   
0%
12.0%
ASMBAssembly Biosciences   1.25   
0%
6.0%
RZLTRezolute   1.00   
0%
5.0%
XOMAXOMA Corp   0.84   
0%
4.0%
NUVBNuvation Bio   0.35   
0%
1.0%
MOLNMolecular Partners   0.17   
1.0%
0%
TARAProtara Therapeutics   0.99   
5.0%
0%
SABSSAB Biotherapeutics   1.02   
5.0%
0%
TPSTTempest Therapeutics   1.04   
5.0%
0%
TILInstil Bio   9.39   
48.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Consideration for investing in Sio Stock

If you are still planning to invest in Sio Gene Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sio Gene's history and understand the potential risks before investing.
Transaction History
View history of all your transactions and understand their impact on performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world